DeepLook Medical

?? Cure & Catalytic Impact Foundation are excited to announce the top six early-stage company finalists addressing a disease or condition predominantly, differently, or exclusively affecting women. All six companies are coming to NYC to pitch their companies live at the Power of X Summit: Solutions to an Untapped Market on Tuesday, March 25th, in front of investors and innovators. Congratulations to Maipl Therapeutics, Inc., Flourish Care, DeepLook Medical, Limax Biosciences, inSoma Bio, and LunaJoy Health. This is your last chance if you haven't registered for the Power of X Summit yet. Use discount code LASTCALL: https://lnkd.in/exgvH-Wv

Did you know that according to the American Cancer Society, approximately?40-50%?of women have dense breasts? Dense breast tissue, made up of fibrous and glandular tissue, can make it harder for doctors to detect abnormalities like cancer during a mammogram. Why is this important? ?? ? Dense breast tissue is linked to an increased risk of breast cancer. ?It can "hide" tumors in mammograms, making early detection harder. Understanding your breast density and discussing screening options with your doctor could save lives. Learn more about breast density and the latest research to improve detection: #BreastCancerAwareness #DenseBreasts #BreastHealth #EarlyDetection #CancerResearch #BCRF #HealthTips

???? ???????? ?? ????????, we're thrilled to feature Marissa Fayer, CEO of HERhealthEQ and DeepLook Medical, as a panelist on our upcoming live discussion, Built for Her: Funding, fixing, and fueling the next era of MedTech. Marissa is an internationally recognized advocate for women's health, TEDx speaker, and award-winning entrepreneur who has spearheaded initiatives improving healthcare access for over 30,000 women globally. The event is ???????? ????????????????, March 20th. Sign up to hear the latest thinking and experiences from Marissa and other female leaders on Thursday! Live Q&A throughout the event, too. Link below. ? ?? https://lnkd.in/etYhMVc9 #MedTech #WomensHealth #HealthEquity #HERhealthEQ #MedicalDevices #ClinicalTrials

New research highlights the significant impact of breast density on both breast cancer risk and mammography sensitivity. Women with dense breasts have a 1.8x higher likelihood of being diagnosed with breast cancer compared to those with less dense tissue. The study found that mammography is less effective in detecting cancer in dense breasts, increasing the risk of missed diagnoses and interval cancers. The study, led by Dr. JANE LANGE from Oregon Health & Science University, emphasizes that while mammograms are less sensitive for dense breasts, frequent screening can improve early detection. These findings support recent U.S. regulations requiring mammography centers to inform patients about breast density and its implications, starting September 2024. Learn more in Femtech World's article:

Our CEO Marissa Fayer just published her first article in MedCity News! "What if just 10% of the $500 billion was allocated to women’s health?" Such an investment could drive advancements in areas like cancer vaccines, AI-powered diagnostic tools, predictive health analytics, research tailored to women's unique health needs, and more. With women making up 51% of the population, Marissa advocates for more focus on women's health, addressing disparities in healthcare and clinical trials, and promoting equitable access to innovative healthcare solutions. Check out the full article below:

At DeepLook Medical, we are transforming how radiologists and healthcare professionals visualize and interpret medical imaging.?We believe in a future where data-driven imaging enhances personalized, efficient treatment for every patient, and we are proud to partner with innovators in medical imaging worldwide. ?? Ft: Anjali Malik

Tomorrow marks International Women's Day and what better way to celebrate than by highlighting the enormous opportunity in women's health? “$350 million in research focused on women could yield $14 billion in economic returns. Doubling investment in women-focused research for coronary artery disease alone could save nearly $2 billion in healthcare costs. Closing the 25% gap in women’s health outcomes could add at least $1 trillion to annual global GDP by 2040, generating a $3 return in economic growth for every $1 invested.” -Women's Health Access Matters 2025 "The Business Case for Accelerating Women's Health Investment" Report

From clinical trial diversity to regulatory and investment hurdles, advancing women's health in MedTech isn’t easy. But those who break through ?????? ???????????????? ??????????. We're bringing together ???????? ???? ?????????? ?????????????? ?????? ?????????? ?????????????? ???? ?????? ?????????? for our next live panel discussion. As part of our ???? ???????? ??????????’?? ???????????? ???????????? campaign, this free event will bring together a powerhouse panel (really!) of influential women to share real-world strategies for accelerating progress in women’s health. ?? ?????? ??????????: Marissa Fayer – CEO, HERhealthEQ ?????? DeepLook Medical Megan Callanan – US & Global Regulatory Lead, Natural Cycles° Stephanie Kladakis – EVP, Chief Technology & Regulatory Officer, AgNovos Bioscience Alexia Haralambous – Senior Principal, RQM+ Moderated by Jaishankar Kutty, Ph.D., VP of Global Regulatory Affairs at RQM+ ???????? ????'???? ??????????: ???? The business case for investing in women’s health ?? The toughest regulatory & market hurdles—and how to overcome them ???? How clinical trials are evolving to close the data gap ?? Lessons from industry pioneers bringing innovations to life ?????????? ??????????????: ?? March 20 | 11am ET / 4pm CET | Live panel with Q&A throughout ?? Have tough questions? ?????? ????????. This is a live, unfiltered conversation designed to give you practical, actionable insights. ???????? ???? ???? ?????? ?????????? at the link in the comments! ?? #MedTech #WomensHealth #ClinicalTrials #RegulatoryAffairs

"Breast?cancer is the most common cancer in women in the United States, except for skin cancers. It accounts for about 30% (or 1 in 3) of all new female cancers each year. The?American Cancer Society's estimates for breast cancer in the United States for 2025 are: ?? About 316,950 new cases of invasive breast cancer will be diagnosed in women. ??About 59,080 new cases of?ductal carcinoma in situ (DCIS)?will be diagnosed. ??About 42,170 women will die from breast cancer." All of these women deserve better tools to help them get the answers they deserve in a timely manner to help them make the most informed decisions."

"What it means to have dense breasts as Julia Bradbury backs AI cancer detection" Learn more about Julia's cancer journey and why she believes women with dense breasts deserve better tools: https://lnkd.in/dY4BEVBv